THE SHARE:
Change: -0.01 SEK (-4.44%) / Price: 0.17 SEK / Dec 6, 2024, 6:00 pm (CET)
Home
About
Introduction
Board of Directors
Management Team
Medical Advisors
Corporate Governance
Career
Technology
Physiological Targeting
Functional Nanoparticles
Publications
Patent
Portfolio
Pipeline
SpagoPix
Tumorad
Investor Relations
The Share
Analyst Coverage
Owners
Financial Reports
Financial Calendar
Equity research
Shareholder’s Personal Data
Share Issue
Media
Spago Nanomedical in media
Press Releases
Subscribe
Presentations
Events
Image Bank
Contact
Contact us
Spago Nanomedical in media
14 Dec, 2023
First patient dosed in Spago’s phase I/IIa trial – BioStock
First patient dosed in Spago’s phase I/IIa trial – BioStock
Back